SUMMARY The effect of hypothyroxinaemia on postnatal progression of the motor nerve conduction velocity was studied in 33 very low birthweight infants.
throughout the study. Three of these infants needed mechanical ventilation and one had an intraventricular haemorrhage. Twenty six infants developed hypothyroxinaemia (thyroxine <60 nmol/l). The nerve conduction velocity was delayed in 13 infants, two on day 21 and 11 at 40 weeks' postmenstrual age. The delay was equivalent to 1 9-4*4 weeks. All these infants belonged to the group with depressed thyroxine concentrations. The delay in progression in nerve conduction velocity was associated with prolonged hypothyroxinaemia, especially in those infants who also required ventilation. Further studies are in progress to study the effect of thyroid hormone on the nerve conduction velocity in preterm infants.
Low thyroxine concentrations are well documented in preterm infants, especially those who are less mature or have respiratory distress syndrome.1 2 A combination of low thyroxine concentrations with raised thyroid stimulating hormone concentrations has been reported in only one study and was due to a relative iodine deficiency.3 In all other reports low thyroxine concentrations have been associated with either normal or low thyroid stimulating hormone concentrations. It has therefore been assumed that low thyroxine concentrations are an expression either of immaturity or of a disturbance of the hypothalamic-pituitary-thyroid axis. 4 Whether the disturbance is secondary to, or associated with, abnormal cerebral metabolism in association with the periventricular-intraventricular haemorrhage to which these infants are prone has so far not been documented.5
Low thyroxine concentrations normalise spontaneously over three to nine weeks.6 7 No consistent physiological disturbances have been noted in these immature infants, nor is it known whether these transient low thyroxine concentrations have a similar harmful effect on the developing nervous system, as noted in children with prolonged hypothyroxinaemia due to congenital hypothyroidism. Delayed myelination has been observed in hypothyroidism, both in humans and animals. Triiodothyronine concentrations were found to be immeasurable (<0-6 nmol/l (0.04 ng/ml)) in 24 of our 33 infants during the first three days of life. Triiodothyronine concentrations were still below 0-6 nmol/l on day 7 in 17 infants. Only one infant with a triiodothyronine concentration below 0-6 nmol/l on day 7 belonged to group 1, the other 16 belonging to 
Although the triiodothyronine concentrations tended to rise during the study in both groups, the mean concentration in group 2 was still low on day 21 (0-85 nmolIl (0-055 ng/ml)).
Thyroid stimulating hormone concentrations remained below 20 mU/l in all infants throughout the study, but in three of these there was a raised concentration on one occasion only (on day 3, range 102-19*8 mU/l). All other thyroid stimulating hormone concentrations were normal (range <1-7-5 mU/l).
Nerve conduction velocity. Normal postnatal acceleration of the nerve conduction velocity was found in 20 infants, while the velocity was delayed in 13 infants. In group 1 (with normal thyroxine concentrations) the nerve conduction velocity was normal on day 21 and at 40 weeks' postmenstrual age ( Fig.  1(a) ).
In group 2 (with one or more low thyroxine concentrations) the nerve conduction velocity was delayed in 13 of the 26 infants at 40 weeks' postmenstrual age. Two of these infants already showed a slow velocity at 21 days, whereas the remainder were normal at that stage. The other 11 showed a normal increase between the first and the third week of life and the delay was first noted at 40 weeks' postmenstrual age ( Fig. 1(b) ). The incidence of delay in nerve conduction velocity at 40 weeks' postmenstrual age, of 1.9 weeks or more, was significantly different between the two groups (p<0-02 by one tailed Fisher exact test).
Ten of the 13 infants with a delay in nerve conduction velocity had prolonged hypothyroxinaemia (low thyroxine concentrations on day 7 and 21) (Fig. 2) . Nine of these 10 infants required ventilation. Eight further infants had prolonged hypothyroxinaemia but a normal nerve conduction velocity at 40 weeks' postmenstrual age, and only three of these infants were ventilated. A combination of ventilation and prolonged hypothyroxinaemia was thus present in nine of the 13 infants with a delay in nerve conduction velocity and in only three of the 13 (p<O.OS).
Discussion
Our findings support previous observations that prematurity and severe illness are associated with a disturbance of the thyroid axis and thus with hypothyroxinaemia in the absence of increased thyroid stimulating hormone concentrations. Twenty six (78%) of our patients developed thyroxine concentrations below 60 nmolI and 21 (65%) still had concentrations below 60 nmol/l at 3 weeks of age. The high incidence of hypothyroxinaemia and the slow recovery rate in this study, compared with other studies,6 are most likely due to the immaturity of our population.
The high incidence of periventricular-intraventricular haemorrhage in the population might be another important associated factor in the hypothalamic disturbance. Fifteen of the 26 infants with low thyroxine concentrations had an associated haemorrhage compared with only one of seven with normal concentrations. It is noteworthy, however, that in six infants low thyroxine concentrations were already present before the bleed could be visualised by ultrasonography and no correlation could be found between the size of the bleed and the degree of the endocrine disturbance. It is thus possible that the hypothalamus is not directly affected by the haemorrhage itself but by the circulatory disturbance leading to it.
This study also shows that the hypothyroxinaemia may be prolonged beyond the first two to three weeks of life. This is supported by the results of Chowdry, who studied a comparable population and only found stabilisation of serum thyroxine between 7 and 9 weeks postnatally.7 Only seven of our infants could be tested at 40 weeks' postmenstrual age, and two still had a thyroxine concentration below 70 nmol/l. Unfortunately, we were unable to document the exact duration of the hypothyroxinaemia in most of our infants as most of them were referred back to the referring hospital shortly after the end of the study.
This study also shows an association between thyroxine concentrations and nerve conduction velocity. Normal maturation was found in all infants with normal thyroxine concentrations, whereas 13 of the 26 infants with low concentrations had a delayed maturation. The nerve conduction velocity seemed to be more often delayed in those infants who still had thyroxine concentrations below 60 nmol/l on day 21. A number of infants, however, had a normal nerve conduction velocity at 40 weeks' postmenstrual age in spite of prolonged hypothyroxinaemia. While most of the infants with prolonged hypothyroxinaemia and a delay in nerve conduction velocity were preterm infants who required ventilation, most of the infants with prolonged hypothyroxinaemia and a normal nerve conduction velocity were healthy. Thus it is possible that slow nerve conduction velocity may be caused by a third unmeasured factor associated with illness. An effect of nutrition on growth and myelination cannot be excluded, but the similar weight gain at 40 weeks' postmenstrual age of the infants with and without delayed nerve conduction velocity makes this unlikely.
There is an established association with hypothyroidism and delayed maturation in congenital hypothyroidism and in hypothyroidism in adults.9 14 Two explanations have been given in these studies for the delayed nerve conduction velocity-delay in myelination and disturbance in the neurotransmitter mechanism. 15 Previously, there has been no biological evidence that transient hypothyroxinaemia associated with prematurity is harmful, but the question whether treatment is indicated is often raised. 16 These results suggest that transient hypothyroxinaemia may interfere with neurological maturation, as shown by delay in maturation of nerve conduction velocity, and raise the question whether treatment of hypothyroxinaemia may influence the maturation of nerve conduction velocity. Two studies have been reported where treatment for hypothyroxinaemia was given. In one prophylactic treatment with triiodothyronine or thyroxine was used in all preterm infants less than 37 weeks' gestation or below 2200 g, or both, with a fourfold reduction in the mortality in the treated group.17 In the other study thyroxine was selectively administered for treatment of preterm infants between 25 and 28 weeks' gestation with two or more thyroxine concentrations below 60 nmol1.7 The outcome between the treated and non-treated group was not different, but only eight of the 23 infants were seen at follow up. Although the increase in thyroxine concentrations was not different between the two groups, no triiodothyronine concentrations were reported and an increased conversion of thyroxine into triiodothyronine cannot therefore be excluded.
Our aim in the present study was to establish a method that would enable us to measure on a short term basis the biological effect of thyroid function. We were able to show an association between disturbed thyroid function and delay in nerve conduction velocity. Whether this delay is mainly influenced by thyroxine concentrations can best be evaluated by the effect of treatment of hypothyroxinaemia on nerve conduction velocities, and such a prospective study is currently in progress in our unit. 
